Related Experiment Video
Updated: May 20, 2025

Using Nicotine in a Silica-Exposed Mouse Model to Promote Lung Epithelial-Mesenchymal Transition
Published on: March 3, 2023
Next-generation immunotherapeutic strategy and clinical advances of vaccines against nicotine addiction
Kun Yan1, Shan Xu1, Hufeng Fang1
1Department of Pharmacy, The Third Affiliated Hospital of Nanjing Medical University, Changzhou,China.
Abstract:
Smoking causes death of millions of people every year. However, available therapies for nicotine addiction are partially effective and exhibit frequent side effects. Thus vaccines targeted at drug nicotine not brain offer a promising strategy to treat nicotine addiction. They cannot pass blood-brain barrier, avoiding serious side effects relevant with central nervous system. The specific nicotine antibody produced by vaccines would convert to complex after combined with nicotine in serum, decreasing or even blocking the distribution of nicotine in brain. This review summarizes the pre-clinical and clinical advances of nicotine vaccines and then addresses future directions of nicotine vaccine and the practical aspects of deployments.
Insights
Nicotine vaccines offer a promising strategy for addiction treatment by preventing nicotine from reaching the brain, avoiding central nervous system side effects. This review covers advances and future directions for nicotine vaccines.
Area of Science:
- Pharmacology
- Immunology
- Addiction Medicine
Background:
- Smoking causes millions of deaths annually.
- Current nicotine addiction therapies have limited efficacy and side effects.
- Nicotine addiction remains a significant global health challenge.
Purpose of the Study:
- To review the pre-clinical and clinical progress of nicotine vaccines.
- To discuss future research and deployment strategies for nicotine vaccines.
- To highlight the potential of vaccines in treating nicotine addiction.
Main Methods:
- Review of pre-clinical studies on nicotine vaccine efficacy and safety.
- Analysis of clinical trial data for nicotine vaccines.
- Evaluation of the mechanism of action for nicotine vaccines.
Main Results:
- Nicotine vaccines generate antibodies that bind nicotine in the bloodstream.
- This binding prevents nicotine from crossing the blood-brain barrier.
- Pre-clinical and early clinical data suggest potential efficacy and safety.
Conclusions:
- Nicotine vaccines represent a novel therapeutic approach for nicotine addiction.
- Their ability to avoid central nervous system side effects is a key advantage.
- Further research and development are needed for successful deployment.
More Related Videos
08:47Spectral Confocal Imaging of Fluorescently tagged Nicotinic Receptors in Knock-in Mice with Chronic Nicotine Administration
Published on: February 10, 2012
09:25Methods to Evaluate Cytotoxicity and Immunosuppression of Combustible Tobacco Product Preparations
Published on: January 10, 2015
Related Concept Videos
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Stimulants
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
Tumor Immunotherapy
CNS Depressants: Alcohol and Nicotine
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...